Harry Visser, DPM
Foot & Ankle Surgery · Creve Coeur, MONPI 1285648576
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,640 of the $20,973 with a category attached, or 74.6%. Arthrex accounts for 74.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $7,358 and has fallen 99.7% since, to $22 in 2025.
Across 79 payments — averaging $265.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$16K
- Elite Orthopedics, LLC$2K
- Stryker$2K
- Orthofix Medical, Inc.$416
- Kerecis Limited$348
- Musculoskeletal Transplant Foundation Inc.$129
- plus $638 from 16 others
What the payments were for
- Speaking & faculty fees$15,64075%
- Travel & lodging$5212%
- Food & beverage$3,61217%
- Education$1,2006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $15,640 |
| Elite Orthopedics, LLC | 16 | $2,156 |
| Stryker(2 entities) | 21 | $1,646 |
| Orthofix Medical, Inc. | 5 | $416 |
| Kerecis Limited | 2 | $348 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $129 |
| Treace Medical Concepts, Inc. | 2 | $122 |
| Medartis Inc. | 2 | $83 |
| ETS Wound Care LLC | 3 | $65 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Melinta Therapeutics, LLC | 2 | $39 |
| Zimmer Biomet | 2 | $38 |
| Axogen | 2 | $35 |
| Medtronic | 1 | $34 |
| Smith+Nephew | 2 | $32 |
| Medline Industries LP | 1 | $29 |
| Polarityte, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $19 |
| Abbott | 1 | $18 |
| Biocomposites Inc | 1 | $14 |
| Misonix Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 GraftGuide$348
- Kerecis Omega3 SurgiClose$348
- Kerecis Omega3 Marigen$346
- SALVATION$282
- Kerecis Omega3 Wound$233
- Kerecis Omega3 Surgibind$233
- AUGMENT INJECTABLE$175
- MiniRail System$154
- ORTHOLOC 2 LAPIFUSE$149
- TL-HEX TRUELOK HEXAPOD SYSTEM$125
- TrueLok$118
- CROSSCHECK$115
- AUGMENT$110
- N/A$106
- BIOskin$105
- 7 X 23MM CITRELOCK IMPLANT$100
How this compares
$20,973 in reported general payments places this provider in the 80th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $170 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $124 |
| Methylprednisolone | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Creve Coeur
- Carmina QuirogaCreve Coeur$23K
- Krystle ScottCreve Coeur$13K
- Shirley VisserCreve Coeur$13K
- Jared VisserCreve Coeur$13K
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.